Tumor heterogeneity, single-cell sequencing, and drug resistance

Pharmaceuticals

Volumn 9, Issue 2, 2016, Pages

  Schmidt, Felix ^a   Efferth, Thomas ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Cancer treatment; Circulating tumor cells; Flow cytometry; Individualized therapy; Intratumoral heterogeneity; Laser capture microdissection; Micromanipulation; Multi region sequencing; Next generation sequencing; Precision medicine; RNA sequencing; Single cell sequencing; Tumor ecosystems; Whole genome amplification; Xenograft tumor models

Indexed keywords

CANCER RESISTANCE; CANCER THERAPY; CELL HETEROGENEITY; CELL ISOLATION; CIRCULATING TUMOR CELL; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE AMPLIFICATION; HUMAN; INVESTIGATIVE PROCEDURES; LASER CAPTURE MICRODISSECTION; MICROMANIPULATION; NEXT GENERATION SEQUENCING; NONHUMAN; PERSONALIZED MEDICINE; PHENOTYPE; REVIEW; SINGLE CELL ANALYSIS; SINGLE CELL SEQUENCING; TUMOR XENOGRAFT; WHOLE GENOME AMPLIFICATION;

EID: 84976543728     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph9020033     Document Type: Review

References (57)

1. Nowell, P.C. The clonal evolution of tumor cell populations. Science 1976, 194, 23-28
2. Hultborn, K.A. Cancer of the colon and rectum; a clinical and pathological study with special reference to the possibilities of improving the diagnostic methods and the therapeutic results in adenocarcinoma. Acta Chir. Scand. Suppl. 1952, 172, 7-190
3. Heppner, G.H. Tumor heterogeneity. Cancer Res. 1984, 44, 2259-2265
4. Heppner, G.H.; Shekhar, M. Tumor heterogeneity is fundamental to the tumor ecosystem. Oncology (Williston Park) 2014, 28, 780-781
5. Allison, K.H.; Sledge, G.W. Heterogeneity and cancer. Oncology (Williston Park) 2014, 28, 772-778
6. Navin, N.; Hicks, J. Future medical applications of single-cell sequencing in cancer. Genome Med. 2011, 3, 31
7. Owens, B. Genomics: The single life. Nature 2012, 491, 27-29
8. Emmert-Buck, M.R.; Bonner, R.F.; Smith, P.D.; Chuaqui, R.F.; Zhuang, Z.; Goldstein, S.R.; Weiss, R.A.; Liotta, L.A. Laser capture microdissection. Science 1996, 274, 998-1001
9. Rosenberg, A.Z.; Armani, M.D.; Fetsch, P.A.; Xi, L.; Pham, T.T.; Raffeld, M.; Chen, Y.; O’Flaherty, N.; Stussman, R.; Blackler, A.R.; et al. High-Throughput Microdissection for Next-Generation Sequencing. PLoS ONE 2016, 11, e0151775
10. Hulett, H.R.; Bonner, W.A.; Barrett, J.; Herzenberg, L.A. Cell sorting: Automated separation of mammalian cells as a function of intracellular fluorescence. Science 1969, 166, 747-749
11. Blanco, L.; Bernad, A.; Lazaro, J.M.; Martin, G.; Garmendia, C.; Salas, M. Highly efficient DNA synthesis by the phage phi 29 DNA polymerase. Symmetrical mode of DNA replication. J. Biol. Chem. 1989, 264, 8935-8940
12. Dean, F.B.; Hosono, S.; Fang, L.; Wu, X.; Faruqi, A.F.; Bray-Ward, P.; Sun, Z.; Zong, Q.; Du, Y.; Du, J.; et al. Comprehensive human genome amplification using multiple displacement amplification. Proc. Natl. Acad. Sci. USA 2002, 99, 5261-5266
13. Chen, M.; Song, P.; Zou, D.; Hu, X.; Zhao, S.; Gao, S.; Ling, F. Correction: Comparison of Multiple Displacement Amplification (MDA) and Multiple Annealing and Looping-Based Amplification Cycles (MALBAC) in Single-Cell Sequencing. PLoS ONE 2015, 10, e0124990
14. Hou, Y.; Wu, K.; Shi, X.; Li, F.; Song, L.; Wu, H.; Dean, M.; Li, G.; Tsang, S.; Jiang, R.; et al. Comparison of variations detection between whole-genome amplification methods used in single-cell resequencing. GigaScience 2015, 4, 37
15. Mardis, E.R. Next-generation DNA sequencing methods. Annu. Rev. Genom. Hum. Genet. 2008, 9, 387-402
16. Metzker, M.L. Sequencing technologies-The next generation. Nat. Rev. Genet. 2010, 11, 31-46
17. EQC/MAQC-III Consortium. A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequence Quality Control consortium. Nat. Biotechnol. 2014, 32, 903-914.
18. Zhang, J.; Fujimoto, J.; Zhang, J.; Wedge, D.C.; Song, X.; Zhang, J.; Seth, S.; Chow, C.-W.; Cao, Y.; Gumbs, C.; et al. Intra-tumor Heterogeneity in Localized Lung Adenocarcinomas Delineated by Multi-region Sequencing. Science 2014, 346, 256-259
19. Yates, L.R.; Gerstung, M.; Knappskog, S.; Desmedt, D.; Gundem, G.; Van Loo, P.; Aas, T.; Alexandrov, L.B.; Larsimont, D.; Davies, H.; et al. Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat. Med. 2015, 21, 751-759
20. Niknafs, N.; Beleva-Guthrie, V.; Naiman, D.Q.; Karchin, R. SubClonal Hierarchy Inference from Somatic Mutations: Automatic Reconstruction of Cancer Evolutionary Trees from Multi-region Next Generation Sequencing. PLoS Comput. Biol. 2015, 11, e1004416
21. Jamal-Hanjani, M.; Wilson, G.A.; Horswell, S.; Mitter, R.; Sakarya, O.; Constantin, T.; Salari, R.; Kirkizlar, E.; et al. Detection of Ubiquitous and Heterogeneous Mutations in Cell-Free DNA from Patients with Early-Stage Non-Small-Cell Lung Cancer. Ann. Oncol. 2016, 27, 862-867
22. Yardley, D.A. Drug resistance and the role of combination chemotherapy in improving patient outcomes. Int. J. Breast Cancer 2013, 2013, 137414
23. Pluen, A.; Boucher, Y.; Ramanujan, S.; McKee, T.D.; Gohongi, T.; di Tomaso, E.; Brown, E.B.; Izumi, Y.; Campbell, R.B.; Berk, D.A.; et al. Role of tumor-host interactions in interstitial diffusion of macromolecules: Cranial vs. subcutaneous tumors. Proc. Natl. Acad. Sci. USA 2001, 98, 4628-4633
24. Jain, R.K. Delivery of molecular and cellular medicine to solid tumors. Adv. Drug Deliv. Rev. 2001, 46, 149-168
25. Efferth, T.; Konkimalla, V.B.; Wang, Y.F.; Sauerbrey, A.; Meinhardt, S.; Zintl, F.; Mattern, J.; Volm, M. Prediction of broad spectrum resistance of tumors towards anticancer drugs. Clin. Cancer Res. 2008, 14, 2405-2412
26. Gottesman, M.M.; Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 1993, 62, 385-427
27. Gottesman, M.M.; Fojo, T.; Bates, S.E. Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat. Rev. Cancer 2002, 2, 48-58
28. Ullah, M.F. Cancer multidrug resistance (MDR): A major impediment to effective chemotherapy. Asian Pac. J. Cancer Prev. 2008, 9, 1-6
29. Gottesman, M.M. Mechanisms of cancer drug resistance. Annu. Rev. Med. 2002, 53, 615-627
30. Volm, M.; Koomagi, R.; Mattern, J.; Efferth, T. Protein expression profiles indicative for drug resistance of non-small cell lung cancer. Br. J. Cancer 2002, 87, 251-257
31. Volm, M.; Koomagi, R.; Mattern, J.; Efferth, T. Expression profile of genes in non-small cell lung carcinomas from long-term surviving patients. Clin. Cancer Res. 2002, 8, 1843-1848
32. Saeed, M.; Khalid, H.; Sugimoto, Y.; Efferth, T. The lignan, (-)-sesamin reveals cytotoxicity toward cancer cells: Pharmacogenomic determination of genes associated with sensitivity or resistance. Phytomedicine 2014, 21, 689-696
33. Saeed, M.; Kuete, V.; Kadioglu, O.; Bortzler, J.; Khalid, H.; Greten, H.J.; Efferth, T. Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking. Phytomedicine 2014, 21, 1525-1533
34. Kuete, V.; Fouotsa, H.; Mbaveng, A.T.; Wiench, B.; Nkengfack, A.E.; Efferth, T. Cytotoxicity of a naturally occurring furoquinoline alkaloid and four acridone alkaloids towards multi-factorial drug-resistant cancer cells. Phytomedicine 2015, 22, 946-951
35. Abdelfatah, S.A.; Efferth, T. Cytotoxicity of the indole alkaloid reserpine from Rauwolfia serpentina against drug-resistant tumor cells. Phytomedicine 2015, 22, 308-318
36. Gillet, J.P.; Efferth, T.; Steinbach, D.; Hamels, J.; de Longueville, F.; Bertholet, V.; Remacle, J. Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes. Cancer Res. 2004, 64, 8987-8993
37. Miyamoto, D.T.; Zheng, Y.; Wittner, B.S.; Lee, R.J.; Zhu, H.; Broderick, K.T.; Desai, R.; Fox, D.B.; Brannigan, B.W.; Trautwein, J.; et al. RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance. Science 2015, 349, 1351-1356
38. Ni, X.; Zhuo, M.; Su, Z.; Duan, J.; Gao, Y.; Wang, Z.; Zong, C.; Bai, H.; Chapman, A.R.; Zhao, J.; et al. Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proc. Natl. Acad. Sci. USA 2013, 110, 21083-21088
39. Pestrin, M.; Salvianti, F.; Galardi, F.; De Luca, F.; Turner, N.; Malorni, L.; Pazzagli, M.; Di Leo, A.; Pinzani, P. Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients. Mol. Oncol. 2015, 9, 749-757
40. Ting, D.T.; Wittner, B.S.; Ligorio, M.; Jordan, V.N.; Shah, A.M.; Miyamoto, D.T.; Aceto, N.; Bersani, F.; Brannigan, B.W.; Xega, K.; et al. Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells. Cell. Rep. 2014, 8, 1905-1918
41. Maheswaran, S. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 2014, 158, 1110-1122.
42. Fernandez, S.V.; Bingham, C.; Fittipaldi, P.; Austin, L.; Palazzo, J.; Palmer, G.; Alpaugh, K.; Cristofanilli, M. TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients. Breast Cancer Res. 2014, 16, 445
43. Morimoto, A.; Mogami, T.; Watanabe, M.; Iijima, K.; Akiyama, Y.; Katayama, K.; Futami, T.; Yamamoto, N.; Sawada, T.; Koizumi, F.; et al. High-Density Dielectrophoretic Microwell Array for Detection, Capture, and Single-Cell Analysis of Rare Tumor Cells in Peripheral Blood. PLoS ONE 2015, 10, e0130418
44. Greene, H.S. The significance of the heterologous transplantability of human cance. Cancer 1952, 5, 24-44
45. Kim, K.T.; Lee, H.W.; Lee, H.O.; Kim, S.C.; Seo, Y.J.; Chung, W.; Eum, H.H.; Nam, D.H.; Kim, J.; Joo, K.M.; et al. Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells. Genome Biol. 2015, 16, 127
46. Eirew, P.; Steif, A.; Khattra, J.; Ha, G.; Yap, D.; Farahani, H.; Gelmon, K.; Chia, S.; Mar, C.; Wan, A.; et al. Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution. Nature 2015, 518, 422-426
47. Melchor, L.; Brioli, A.; Wardell, C.P.; Murison, A.; Potter, N.E.; Kaiser, M.F.; Fryer, R.A.; Johnson, D.C.; Begum, D.B.; Hulkki Wilson S.; et al. Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma. Leukemia 2014, 28, 1705-1715
48. The precision medicine initiative. Available online: https://www.whitehouse.gov/precision-medicine (accessed on 25 March 2016).
49. Chen, C.; He, M.; Zhu, Y.; Shi, L.; Wang, X. Five critical elements to ensure the precision medicine. Cancer Metast. Rev. 2015, 34, 313-318
50. Wang, X. Gene mutation-based and specific therapies in precision medicine. J. Cell. Mol. Med. 2016, 20, 577-580
51. Chang, W.; Brohl, A.S.; Patidar, R.; Sindiri, S.; Shern, J.F.; Wei, J.S.; Song, Y.K.; Yohe, M.E.; Gryder, B.E.; Zhang, S.; et al. Multi-dimensional ClinOmics for precision therapy of children and adolescent young adults with relapsed and refractory cancer: A report from the Center for Cancer Research. Clin. Cancer Res. 2016
52. Chan, S.L.; Wong, A.M.; Lee, K.; Wong, N.; Chan, A.K.C. Personalized therapy for hepatocellular carcinoma: Where are we now? Cancer Treatm. Rev. 2016, 45, 77-86
53. Gomy, I.; Diz, M.D. Hereditary cancer risk assessment: Insights and perspectives for the next-generation sequencing era. Genet. Mol. Biol. 2016, 39, 184-188, pii: S1415-47572016005001102
54. Wetterstrand, K. DNA Sequencing costs: Data from the NHGRI Genome Sequencing Program (GSP). Available online: https://www.genome.gov/sequencingcostsdata/ (accessed on 12 June 2016).
55. Lesho, E.; Clifford, R.; Onmus-Leone, F.; Appalla, L.; Snesrud, E.; Kwak, Y.; Ong, A.; Maybank, R.; Waterman, P.; Rohrbeck, P.; et al. The challenges of implementing next generation sequencing across a large healthcare system, and the molecular epidemiology and antibiotic susceptibilities of carbapenemase-producing bacteria in the healthcare system of the U.S. Department of Defense. PLoS ONE 2016, 11, e0155770
56. Rangachari, D.; VanderLaan, P.A.; Le, X.; Folch, E.; Kent, M.S.; Gangadharan, S.P.; Majid, A.; Haspel, R.L.; Joseph, L.J.; Huberman, M.S.; et al. Experience with targeted next generation sequencing for the care of lung cancer: Insights into promises and limitations of genomic oncology in day-to-day practice. Cancer Treat. Commun. 2015, 4, 174-181
57. The cost of sequencing a human genome. Available online: https://www.genome.gov/sequencingcosts/ (accessed on 12 June 2016)